Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.

    Virtual Booth

    Contact Supplier

    Coral

    Virtual Booth

    Contact Supplier

    ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

    Virtual Booth

    Contact Supplier

    Menu

    Atezolizumab

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Akeso Starts Global Cadonilimab Trial in Resistant Liver Cancer
    Akeso Starts Global Cadonilimab Trial in Resistant Liver Cancer

    15 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/akeso-announces-first-patient-dose-in-global-registrational-trial-of-cadonilimab-pd-1ctla-4-for-pd-1-treatment-resistant-hepatocellular-carcinoma-302555984.html

    PR NEWSWIRE
    15 Sep 2025
    Share Share
    IMvigor011 Shows Positive Results, Signatera Predicts Benefit
    IMvigor011 Shows Positive Results, Signatera Predicts Benefit

    18 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250818904141/en/IMvigor011-Bladder-Cancer-Trial-Achieves-Positive-Results-with-Signatera-Strongly-Predicting-Adjuvant-Immunotherapy-Benefit

    BUSINESSWIRE
    18 Aug 2025
    Share Share
    Genentech’s Biologics Tecentriq Receives Suppl Approval in US
    Genentech’s Biologics Tecentriq Receives Suppl Approval in US

    18 Aug 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761347

    FDA
    18 Aug 2025
    Share Share
    Xilio Therapeutics Updates Pipeline, Business, Q2 2025 Financials
    Xilio Therapeutics Updates Pipeline, Business, Q2 2025 Financials

    14 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/14/3133362/0/en/Xilio-Therapeutics-Announces-Pipeline-and-Business-Updates-and-Second-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    14 Aug 2025
    Share Share
    Pilatus, Roche to Test PLT012 in Hepatocellular Carcinoma
    Pilatus, Roche to Test PLT012 in Hepatocellular Carcinoma

    13 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250813741707/en/Pilatus-Biosciences-Announces-Clinical-Trial-Collaboration-with-Roche-to-Evaluate-PLT012-in-First-in-Human-Study-in-Hepatocellular-Carcinoma

    BUSINESSWIRE
    13 Aug 2025
    Share Share
    Exelixis: Zanzalintinib Combo Boosts OS in Colorectal Cancer
    Exelixis: Zanzalintinib Combo Boosts OS in Colorectal Cancer

    22 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250622399674/en/Exelixis-Announces-Zanzalintinib-in-Combination-with-an-Immune-Checkpoint-Inhibitor-Improved-Overall-Survival-in-STELLAR-303-Phase-3-Pivotal-Trial-in-Patients-with-Metastatic-Colorectal-Cancer

    BUSINESSWIRE
    22 Jun 2025
    Share Share